Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Share-based Compensation (2022 - 2025)

Historic Share-based Compensation for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $383000.0.

  • PAVmed's Share-based Compensation changed N/A to $383000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2024, which is 4210.43% down from last year.
  • Latest data reveals that PAVmed reported Share-based Compensation of $383000.0 as of Q3 2025.
  • In the past 5 years, PAVmed's Share-based Compensation ranged from a high of $5.0 million in Q2 2022 and a low of $162000.0 during Q2 2025
  • In the last 4 years, PAVmed's Share-based Compensation had a median value of $2.1 million in 2023 and averaged $2.6 million.
  • As far as peak fluctuations go, PAVmed's Share-based Compensation tumbled by 820.52% in 2023, and later crashed by 9149.16% in 2025.
  • Quarter analysis of 4 years shows PAVmed's Share-based Compensation stood at $4.9 million in 2022, then plummeted by 60.23% to $2.0 million in 2023, then plummeted by 62.75% to $733000.0 in 2024, then plummeted by 47.75% to $383000.0 in 2025.
  • Its last three reported values are $383000.0 in Q3 2025, $162000.0 for Q2 2025, and $930000.0 during Q1 2025.